Spyre Therapeutics, Inc.
Pharmaceutical Preparations · Waltham, MA, United States
- PrincipalsCameron TurtleChief Executive OfficerScott L BurrowsChief Financial OfficerSheldon SloanChief Medical Officerand 2 more
- CompanySpyre Therapeutics, Inc.Waltham, MA, United States
- Phone line+1 (617) 651-5940General business
Spyre Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker SYRE) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 5
Chief executive
Cameron TurtleChief Executive Officer
Chair & board
Michael Thomas HendersonDirector (Board)
Finance
Scott L BurrowsChief Financial Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Cameron Turtle — Chief Executive Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Scott L Burrows — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Sheldon Sloan — Chief Medical Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Heidy King-Jones — Officer (see SEC filing)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Silence Therapeutics plcPharmaceutical Preparations · London1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityTeva Pharmaceutical Industries LtdPharmaceutical Preparations · Tel Aviv1 shared capabilityCrispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityRoivant Sciences Ltd.Pharmaceutical Preparations · London1 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capability